February 20, 2008
Press Release no.1
Security
listed and admitted to dealings – ASTRAZEN
The
following security of AstraZeneca Pharma India Limited shall be listed and
admitted to dealings on the Exchange w.e.f. February 22, 2008. Trading shall be
in the Normal Market Segment – Compulsory Demat (Rolling Settlement) for all
investors.
|
Sr. No. |
Symbol |
Security Name |
Series |
ISIN
Code |
|
1 |
ASTRAZEN |
8% Non-Conv Bonus Deb. |
N1 |
INE203A07019 |
Press Release no.2
Security
listed and admitted to dealings – IRB
The equity
shares of the following company shall be listed and admitted to dealings
on the Exchange w.e.f. February
25, 2008.
Trading shall be in the Normal Market segment – Compulsory Demat (Rolling
Settlement) for all investors.
|
Sr. No. |
Symbol |
Name of the Company |
ISIN Code |
|
1 |
IRB |
IRB Infrastructure Developers
Limited |
INE821I01014 |
Press Release no.3
NSE
completes its 2007th Normal
Settlement
The Exchange has successfully
completed its 2007th Normal Settlement (Rolling T+2 following SEBI
directive) since inception i.e., Settlement Number N – 2008035 on February 20,
2008. The settlement statistics is as follows:
Particulars
|
Values
|
|
|
N – 2008035
|
|
Total traded
quantity (lakhs) |
5116.59 |
|
Total traded
value (Rs. In Crores) |
10899.86 |
|
Total value of
the settlement (Securities) (Rs. In Crores) |
2382.89 |
|
Total value of
the settlement (Funds) (Rs. In Crores) |
651.02 |
Shortages for the settlement
|
0.18% |
|
% of Delivery ( No. of shares deliverable / No.
of shares traded ) |
18.07% |
Retail Debt Market have completed its 1281st
settlements details of which is as follows:
|
Settlement No. |
Traded Value |
Settlement Value |
|
|
|
|
Securities |
Funds |
|
D- 2008035 |
NIL |
NIL |
NIL |